Evidence map›Paper›PMID 36005557›Full record

ArticleHaematologica2022

Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma.

Samir Asher, Aikaterini Kazantzi, Fatjon Dekaj, Luke Steventon, Aisha Khatun, Louise Ainley, Annabel McMillan, Neil Rabin, Ashu Wechalekar, Jonathan Sive and 8 more

Abstract readLetter
In one paragraph

Article in Haematologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Samir AsherNational Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London.
Aikaterini KazantziNational Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London.
Fatjon DekajNational Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London.
Luke SteventonCancer Clinical Trials Unit, University College London Hospitals NHS Trust, London.
Aisha KhatunCancer Clinical Trials Unit, University College London Hospitals NHS Trust, London.
Louise AinleyDepartment of Haematology, University College London Hospitals NHS Trust, London.
Annabel McMillanDepartment of Haematology, University College London Hospitals NHS Trust, London.
Neil RabinDepartment of Haematology, University College London Hospitals NHS Trust, London.
Ashu WechalekarDepartment of Haematology, University College London Hospitals NHS Trust, London.
Jonathan SiveDepartment of Haematology, University College London Hospitals NHS Trust, London.
Charalampia KyriakouDepartment of Haematology, University College London Hospitals NHS Trust, London.
Xenofon PapanikolaouDepartment of Haematology, University College London Hospitals NHS Trust, London.
Ke XuDepartment of Haematology, University College London Hospitals NHS Trust, London.
Shameem MahmoodDepartment of Haematology, University College London Hospitals NHS Trust, London.
Brendan WisniowskiDepartment of Haematology, University College London Hospitals NHS Trust, London.
Lydia LeeDepartment of Haematology, University College London Hospitals NHS Trust, London.
Kwee YongDepartment of Haematology, University College London Hospitals NHS Trust, London.
Rakesh PopatNational Institute for Health Research Clinical Research Facility, University College London Hospitals NHS Trust, London, United Kingdom; Department of Haematology, University College London Hospitals NHS Trust, London. rakesh.popat@ucl.ac.uk.

Funding

Department of HealthMedical Research Council MR/S001883/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiple MyelomaClinical Trials as TopicEthnic and Racial MinoritiesHumansMinority GroupsPatient Selection

Identifiers

PMID36005557
PMCPMC9713550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.